FDA Import Refusal DK8-0056794-5/11/1 — UCB Pharma S.A.
The FDA refused shipment DK8-0056794-5/11/1 from UCB Pharma S.A. (Belgium) on Jul 11, 2019. The refused product falls under Drugs and Biologics — ANTI-PARKINSONIAN N.E.C.. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Jul 11, 2019
- Country
- Belgium
- Product Category
- Drugs and Biologics
- Product Code
- 62JIY99 ANTI-PARKINSONIAN N.E.C.
- Charges
- 75